CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
 9 Months Ended 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Jun. 30, 2012
Jun. 30, 2011
Cash flows from operating activities        
Net loss $ (4,061,186) $ (4,044,466) $ (7,130,059) $ (6,026,641)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation 38,004 38,444 51,301 15,269
Bad debt expense     2,739 13,865
Amortization of debt discounts 349,548 19,957    254,852
Amortization of beneficial conversion feature related to convertible notes     193,044   
Amortization of original issue discounts related to convertible notes     6,924   
Amortization of prepaid expense        46,303
Common stock issued as settlement    300,000 300,000   
Amortization of stock based prepaid consulting    42,500 42,500 213,937
Vesting of restricted stock units 90,000       
Stock option employee compensation expense 1,234,945 1,002,060 1,371,519 921,639
Stock options issued for non-employee services        (322,850)
Loss on extinguishment of debt 21,311       267,390
Cost of repricing warrants to induce exercise 70,491 17,753 17,753   
Loss on disposal of assets 9,822       
Loss on stock issued for interest 4,205       
Common stock issued for services        168,500
Warrants issued to induce warrant exercise        62,414
Reversal of litigation accrual (941,000)       
Payment by insurance company of prior period accrued litigation expense (200,000)       
Changes in assets and liabilities:        
Accounts receivable 5,831 69,069 45,925 (93,042)
Inventories (123,213) (154,137) (152,684) (195,160)
Prepaid expenses and other current assets (44,290) (28,944) 27,930   
Deposits and other assets 11,255       27,198
Accounts payable 202,978 (127,758) (36,490) 244,651
Related party payable          
Accrued expenses 67,001 (83,989) 1,625,067 119,762
Net cash used in operating activities (3,075,253) (2,891,623) (3,634,531) (3,636,213)
Cash flows from Investing Activities        
Proceeds from sale of asset 15,000       
Purchases of equipment (27,973) (28,949) (30,258) (205,077)
Net cash (used in) investing activities (12,973) (28,949) (30,258) (205,077)
Cash flows from Financing Activities        
Proceeds from sale of stock through private placements 1,258,000 566,700 1,181,700 3,272,766
Proceeds from sale of stock under stock purchase agreement 810,003       1,429,320
Proceeds from exercise of warrants 910,000 107,500 65,000 379,129
Proceeds from exercise of stock options    33,335 75,835 122,000
Payment on related party notes (84,219)    105,000   
Proceeds from convertible notes with third parties 175,000 105,000 325,000   
Proceeds from convertible notes with related parties 500,000 325,000 89,380   
Proceeds from related party advances    89,380 (5,000)   
Payments on insurance finance contract (34,752) (33,013) (44,908) (30,745)
Net cash provided by financing activities 3,534,032 1,193,902 1,792,007 5,172,470
Net increase in cash and cash equivalents 445,806 (1,726,670) (1,872,782) 1,331,180
Cash and cash equivalents - beginning 84,194 1,956,976 1,956,976  
Cash and cash equivalents - ending 530,000 230,306 84,194 1,956,976
Supplemental Disclosure of Cash Flow Information:        
Cash paid for interest 836 1,601 2,843 43,548
Cash paid for income taxes            
Supplementary Disclosure of Non-cash Investing and Financing Activities:        
Financing of prepaid insurance contracts 47,471 43,931 43,931 32,837
Line of credit and accrued interest exchanged for convertible debt        1,536,810
Accrued interest financed with convertible note     74,874   
Beneficial conversion feature of convertible notes 195,770 84,562 347,398   
Prepaid option and stock-based consulting        65,500
Conversion of notes for common stock 459,067       1,000,000
Note issued for accrual interest    74,874    
Common stock issued for interest $ 73,579